Your browser doesn't support javascript.
loading
MALDI Mass Spectrometry Imaging-Prognostic Pathways and Metabolites for Renal Cell Carcinomas.
Erlmeier, Franziska; Sun, Na; Shen, Jian; Feuchtinger, Annette; Buck, Achim; Prade, Verena M; Kunzke, Thomas; Schraml, Peter; Moch, Holger; Autenrieth, Michael; Weichert, Wilko; Hartmann, Arndt; Walch, Axel.
Afiliación
  • Erlmeier F; Institute of Pathology, University Hospital Erlangen-Nuremberg, 91054 Erlangen, Germany.
  • Sun N; Research Unit Analytical Pathology, Helmholtz Zentrum München-German Research Center for Environmental Health, 85764 Neuherberg, Germany.
  • Shen J; Research Unit Analytical Pathology, Helmholtz Zentrum München-German Research Center for Environmental Health, 85764 Neuherberg, Germany.
  • Feuchtinger A; Research Unit Analytical Pathology, Helmholtz Zentrum München-German Research Center for Environmental Health, 85764 Neuherberg, Germany.
  • Buck A; Research Unit Analytical Pathology, Helmholtz Zentrum München-German Research Center for Environmental Health, 85764 Neuherberg, Germany.
  • Prade VM; Research Unit Analytical Pathology, Helmholtz Zentrum München-German Research Center for Environmental Health, 85764 Neuherberg, Germany.
  • Kunzke T; Research Unit Analytical Pathology, Helmholtz Zentrum München-German Research Center for Environmental Health, 85764 Neuherberg, Germany.
  • Schraml P; Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
  • Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
  • Autenrieth M; Department of Urology, Rechts der Isar Medical Center, Technical University of Munich, 81675 Munich, Germany.
  • Weichert W; Institute of Pathology, Technical University Munich, 81675 Munich, Germany.
  • Hartmann A; Institute of Pathology, University Hospital Erlangen-Nuremberg, 91054 Erlangen, Germany.
  • Walch A; Research Unit Analytical Pathology, Helmholtz Zentrum München-German Research Center for Environmental Health, 85764 Neuherberg, Germany.
Cancers (Basel) ; 14(7)2022 Mar 30.
Article en En | MEDLINE | ID: mdl-35406537
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Alemania